SGRX
Sangrix Inc.
There isn't enough reported data to score SGRX yet.
SGRX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
SGRX's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
SGRX PE Valuation
SGRX has no meaningful PE right now: it lost money over the past year.
SGRX Forward outlook
There aren't enough analyst estimates for SGRX to show an outlook.
SGRX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2023 | -$2,553.56 | -630% |
| Q2 2022 | $481.94 | +$12,848.06 |
| Q2 2021 | -$12,366.12 | -$10,408.17 |
| Q2 2020 | -$1,957.95 | -204% |
SGRX lost $84.00 per share over the past year, a smaller loss than the year before.
SGRX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2023 | $6.3M | +3155% |
| Q2 2022 | $192.4K | -100% |
| Q2 2021 | $80.5M | -27% |
| Q2 2020 | $110.6M | +7.8% |
SGRX's revenue has slid since its 2020 peak: $0 last quarter, down 100% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2023 | -234% | -234 points |
| Q2 2023 | -452% | -458 points |
| Q2 2022 | -3176% | N/A |
| Q2 2021 | -16% | N/A |
| Q2 2020 | 0.5% | N/A |
| Q2 2019 | 5.4% | N/A |
SGRX's operating margin was −234% last quarter, down 234 points from the same quarter a year ago.
SGRX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2023 | -$6.9M | +$15.7M |
| Q2 2020 | -$6.6M | -$1.3M |
SGRX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +131% | +15.5K shares |
| 1 year | +640% | +23.6K shares |
SGRX has 27,304 diluted shares, up 640% from a year ago.
SGRX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2019 | 0.5x | Very low |
SGRX's net debt is less than a year of its operating earnings (EBITDA).
SGRX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.8 | Oversold |
| Stochastic | 4.0 | Oversold |
SGRX's weekly RSI is 28 (oversold) and its Stochastic is 4 (oversold).
SGRX PE vs Consumer Defensive Sector
| Metric | SGRX | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 19x | — |
SGRX has no meaningful PE right now: it lost money over the past year.
SGRX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.78 | 49% below |
| 20 week MA | $2.55 | 84% below |
| 50 week MA | $14.7 | 97% below |
| 100 week MA | $65.4 | 99% below |
| 200 week MA | $572.8 | 100% below |
SGRX is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
SGRX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $36,540.0 | $8,100.0 | -78% |
| 2021 | $8,100.0 | $12,600.0 | +56% |
| 2022 | $12,600.0 | $1,468.8 | -88% |
| 2023 | $1,468.8 | $1,245.0 | -15% |
| 2024 | $1,245.0 | $273.0 | -78% |
| 2025 | $273.0 | $53.5 | -80% |
| 2026 YTD | $53.5 | $0.40 | -99% |
SGRX has finished four years in a row lower, and it's down 99% so far in 2026.